ARMATA PHARMACEUTICALS, INC.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

ARMP

organization

Jurisdiction: US-WALegal Form: 8888

ACTIVE

LEI: 549300QM1VCWH8KT0S21SIC: 2836

Also known as: Armata Pharmaceuticals, Inc.

SEC Insider

$147.6M

230 transactions

Summary

ARMATA PHARMACEUTICALS, INC. (ARMP) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $146.6MSales: $876K42 insiders

Date	Insider	Type	Value
2026-03-14	Birx Deborah(Chief Executive Officer)	F	$52K
2025-07-10	Birx Deborah(Chief Executive Officer)	F	$31K
2025-03-14	Birx Deborah(Chief Executive Officer)	F	$12K
2026-03-14	Kyme Pierre(Chief Business Officer)	F	$11K
2025-03-14	Kyme Pierre(Chief Business Officer)	F	$2K
2026-04-24	Gilmer Daniel B.	A	$0
2026-03-09	Haimovitz Jules	A	$0
2026-03-09	Schlesinger Sarah J.	A	$0
2026-03-09	Birx Deborah(Chief Executive Officer)	A	$0
2026-03-09	Odysseas Kostas D	A	$0
2026-03-09	Peterson Todd C.	A	$0
2026-03-09	PATTI JOSEPH M	A	$0
2026-03-09	House David Duane(SVP, Finance, and PFO)	A	$0
2026-03-09	Kyme Pierre(Chief Business Officer)	A	$0
2026-03-09	Kramer Robin	A	$0
2025-02-05	Birx Deborah(Chief Executive Officer)	A	$0
2025-02-05	Haimovitz Jules	A	$0
2025-02-05	House David Duane(SVP, Finance, and PFO)	A	$0
2025-02-05	Kramer Robin	A	$0
2025-02-05	Kyme Pierre(Chief Business Officer)	A	$0

Legal entity: GLEIF

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

ARMATA PHARMACEUTICALS, INC. — Contributions, Lobbying & Contracts | Poliscope